|
METAP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.42260000002281E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99269999999752E-05 |
| Normal-vs-Stage2 |
2.174500E-04 |
| Normal-vs-Stage3 |
6.0636999999919E-05 |
| Normal-vs-Stage4 |
3.66280000000385E-05 |
| Stage1-vs-Stage2 |
6.333400E-01 |
| Stage1-vs-Stage3 |
7.020600E-01 |
| Stage1-vs-Stage4 |
4.202000E-01 |
| Stage2-vs-Stage3 |
8.645000E-01 |
| Stage2-vs-Stage4 |
7.946600E-01 |
| Stage3-vs-Stage4 |
6.447800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.559689999997E-05 |
| Normal-vs-AfricanAmerican |
4.548000E-02 |
| Normal-vs-Asian |
7.85380000000169E-05 |
| Caucasian-vs-AfricanAmerican |
3.795000E-01 |
| Caucasian-vs-Asian |
7.015600E-01 |
| AfricanAmerican-vs-Asian |
2.752800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.828220E-04 |
| Normal-vs-Female |
1.0797999999701E-06 |
| Male-vs-Female |
3.875600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.90620000000741E-05 |
| Normal-vs-Age(41-60Yrs) |
3.14650000055039E-07 |
| Normal-vs-Age(61-80Yrs) |
1.595640E-04 |
| Normal-vs-Age(81-100Yrs) |
1.797390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.056200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.977200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.683600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.677600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.518800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.189600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.050000E-01 |
| Classical-VS-Follicular |
2.478000E-02 |
| Classical-VS-Other |
8.650000E-01 |
| Classical-VS-Normal |
6.07859999999238E-05 |
| Tall-VS-Follicular |
9.722500E-02 |
| Tall-VS-Other |
7.295200E-01 |
| Tall-VS-Normal |
4.172200E-02 |
| Follicular-VS-Other |
5.843000E-01 |
| Follicular-VS-Normal |
1.36689999996609E-06 |
| Other-VS-Normal |
9.925900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23529999995764E-06 |
| Normal-vs-N1 |
1.11589999995942E-06 |
| N0-vs-N1 |
2.668800E-01 |
|
|
